PT Ferron Par Pharmaceuticals (Indonesia)

Ferron Par Pharmaceuticals is primarily engaged in pharmaceutical preparations activity. Its headquarters is located in Banten. The company was founded in 1994. Ferron Par Pharmaceuticals was founded by Dr. Boenjamin Setiawan, a prominent figure in the Indonesian pharmaceutical industry. The company is a subsidiary of the Dexa Group, one of Indonesia's largest pharmaceutical conglomerates. Ferron Par Pharmaceuticals focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products, including prescription medications, over-the-counter drugs, and health supplements. The company operates several manufacturing facilities in Indonesia, equipped with state-of-the-art technology to ensure high-quality production standards. Ferron Par Pharmaceuticals has a strong local presence with numerous branches and distribution networks across Indonesia, ensuring its products are widely accessible. In addition to its domestic operations, Ferron Par Pharmaceuticals exports its products to several countries in Southeast Asia, expanding its footprint in the regional market. The company is committed to innovation and research, continuously investing in the development of new and effective pharmaceutical solutions. Ferron Par Pharmaceuticals collaborates with various international pharmaceutical companies and research institutions to enhance its product offerings and stay at the forefront of medical advancements. The company is a member of several industry associations, actively participating in initiatives to improve healthcare standards in Indonesia and beyond. With a mission to improve the quality of life through innovative healthcare solutions, Ferron Par Pharmaceuticals aims to be a leading player in the pharmaceutical industry, both locally and internationally.